VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 3, Pages 868-873
Publisher
American Society of Hematology
Online
2011-10-19
DOI
10.1182/blood-2011-08-372722
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of the VKORC1 Genotype on Warfarin Dose Requirements in Japanese Pediatric Patients
- (2011) Yuya Kato et al. Drug Metabolism and Pharmacokinetics
- The Potential Impact of Dietary Vitamin K Status on Anticoagulation Control in Children Receiving Warfarin
- (2011) Tina T. Biss et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes
- (2010) U. Nowak-Gottl et al. BLOOD
- Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
- (2010) N. A. Limdi et al. BLOOD
- CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
- (2010) Han-Jing Cen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pediatric warfarin practice and pharmacogenetic testing
- (2010) Courtney D. Thornburg et al. THROMBOSIS RESEARCH
- Pharmacogenetics of Warfarin
- (2009) Farhad Kamali et al. Annual Review of Medicine
- CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
- (2009) M. G. McDonald et al. MOLECULAR PHARMACOLOGY
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- The largest prospective warfarin-treated cohort supports genetic forecasting
- (2008) M. Wadelius et al. BLOOD
- A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
- (2008) G. M. Cooper et al. BLOOD
- Antithrombotic Therapy in Neonates and Children
- (2008) Paul Monagle et al. CHEST
- Oral anticoagulation with warfarin is significantly influenced by steroids and CYP2C9 polymorphisms in children with cancer
- (2007) Ellen Ruud et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More